Compare
Herbalife Ltd. vs Cencora, Inc. vs Cosmos Health Inc. vs McKesson Corp
| Latest fiscal year | Herbalife Ltd. HLF | Cencora, Inc. COR | Cosmos Health Inc. COSM | McKesson Corp MCK |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
| Revenue | $5.04B | $321.33B | $65.27M | $403.43B |
| Revenue growth (YoY) | +0.9% | +9.3% | +19.9% | +12.4% |
| Gross margin | 77.9% | 3.6% | 12.1% | 3.6% |
| Operating margin | 9.5% | 0.8% | -25.6% | 1.5% |
| Net margin | 4.5% | 0.5% | -29.3% | 1.2% |
| Net income | $228.30M | $1.55B | -$19.14M | $4.76B |
| EPS (Diluted) | $2.20 | $7.96 | -$0.63 | $38.38 |
| Operating cash flow | $333.30M | $3.88B | -$8.45M | $6.16B |
| Free cash flow | $252.90M | $3.21B | -$8.50M | $5.72B |
| Cash & equivalents | $353.10M | $4.36B | $715.7K | $3.98B |
| Total assets | $2.79B | $76.59B | $65.48M | $82.32B |
| Total liabilities | $3.30B | n/a | $47.05M | n/a |
| Shareholders' equity | -$515.10M | $1.51B | $18.42M | -$1.78B |
| Return on year-end equity | n/a | 103.1% | -103.9% | n/a |
| Shares outstanding | 103.30M | 193.94M | 41.07M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Herbalife Ltd. | Cencora, Inc. | Cosmos Health Inc. | McKesson Corp |
|---|---|---|---|---|
| Latest | $5.04B Ended 2025-12-31 | $321.33B Ended 2025-09-30 | $65.27M Ended 2025-12-31 | $403.43B Ended 2026-03-31 |
| 1 year earlier | $4.99B Ended 2024-12-31 | $293.96B Ended 2024-09-30 | $54.43M Ended 2024-12-31 | $359.05B Ended 2025-03-31 |
| 2 years earlier | $5.06B Ended 2023-12-31 | $262.17B Ended 2023-09-30 | $53.38M Ended 2023-12-31 | $308.95B Ended 2024-03-31 |
| 3 years earlier | $5.20B Ended 2022-12-31 | $238.59B Ended 2022-09-30 | $50.35M Ended 2022-12-31 | $276.71B Ended 2023-03-31 |
| 4 years earlier | $5.80B Ended 2021-12-31 | $213.99B Ended 2021-09-30 | $56.24M Ended 2021-12-31 | $263.97B Ended 2022-03-31 |